<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: QXInteractive; Version: 3.5d -->
    <!-- Field: Doc-Info; Name: Source; Value: GNPB 09302013 S1A.xfr; Date: 2014/01/21T19:26:59 -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://genesis-biopharma.com/role/DocumentAndEntityInformation" xlink:href="gnpb-20130930.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/BalanceSheets" xlink:href="gnpb-20130930.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/BalanceSheetsParenthetical" xlink:href="gnpb-20130930.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StatementsOfOperations" xlink:href="gnpb-20130930.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StatementsOfOperationsParenthetical" xlink:href="gnpb-20130930.xsd#StatementsOfOperationsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StatementsOfCashFlows" xlink:href="gnpb-20130930.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StatementsOfStockholdersEquityDeficiency" xlink:href="gnpb-20130930.xsd#StatementsOfStockholdersEquityDeficiency" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/GeneralOrganizationAndBusiness" xlink:href="gnpb-20130930.xsd#GeneralOrganizationAndBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPractices" xlink:href="gnpb-20130930.xsd#SummaryOfSignificantAccountingPractices" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/RestructuringOfDebt" xlink:href="gnpb-20130930.xsd#RestructuringOfDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/A.IntellectualPropertyLicenses" xlink:href="gnpb-20130930.xsd#A.IntellectualPropertyLicenses" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/EquityRestructuring" xlink:href="gnpb-20130930.xsd#EquityRestructuring" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/A.7SeniorSecuredConvertiblePromissoryNotes" xlink:href="gnpb-20130930.xsd#A.7SeniorSecuredConvertiblePromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/B.12SecuredPromissoryNotes" xlink:href="gnpb-20130930.xsd#B.12SecuredPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/C.September2012SecuredPromissoryNotes" xlink:href="gnpb-20130930.xsd#C.September2012SecuredPromissoryNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/DerivativeLiabilities" xlink:href="gnpb-20130930.xsd#DerivativeLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/A.CommonStock" xlink:href="gnpb-20130930.xsd#A.CommonStock" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StockOptionsAndWarrants" xlink:href="gnpb-20130930.xsd#StockOptionsAndWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/LicenseAndCommitments" xlink:href="gnpb-20130930.xsd#LicenseAndCommitments" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/RelatedPartyTransactions" xlink:href="gnpb-20130930.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/SubsequentEvents" xlink:href="gnpb-20130930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesPolicies" xlink:href="gnpb-20130930.xsd#SummaryOfSignificantAccountingPracticesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesTables" xlink:href="gnpb-20130930.xsd#SummaryOfSignificantAccountingPracticesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/DerivativeLiabilitiesTables" xlink:href="gnpb-20130930.xsd#DerivativeLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StockOptionsAndWarrantTables" xlink:href="gnpb-20130930.xsd#StockOptionsAndWarrantTables" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/SubsequentEventsTables" xlink:href="gnpb-20130930.xsd#SubsequentEventsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/GeneralOrganizationAndBusinessDetailsNarrative" xlink:href="gnpb-20130930.xsd#GeneralOrganizationAndBusinessDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesDetails" xlink:href="gnpb-20130930.xsd#SummaryOfSignificantAccountingPracticesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesDetailsNarrative" xlink:href="gnpb-20130930.xsd#SummaryOfSignificantAccountingPracticesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/DerivativeLiabilitiesDetails" xlink:href="gnpb-20130930.xsd#DerivativeLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StockOptionsAndWarrantsDetails" xlink:href="gnpb-20130930.xsd#StockOptionsAndWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/StockOptionsAndWarrantsDetails1" xlink:href="gnpb-20130930.xsd#StockOptionsAndWarrantsDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/A.StockOptionsAndWarrantsOptionActivityDetails" xlink:href="gnpb-20130930.xsd#A.StockOptionsAndWarrantsOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://genesis-biopharma.com/role/A.StockOptionsAndWarrantsWarrantActivityDetails1" xlink:href="gnpb-20130930.xsd#A.StockOptionsAndWarrantsWarrantActivityDetails1" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/DocumentAndEntityInformation" xlink:title="0001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/BalanceSheets" xlink:title="0002 - Statement - Condensed Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_SecuredPromissoryNotes" xlink:label="loc_GNPBSecuredPromissoryNotes" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_GNPBSecuredPromissoryNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SecuredDebtCurrent" xlink:label="loc_us-gaapSecuredDebtCurrent" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapSecuredDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_AccruedInterestAndPenalty" xlink:label="loc_GNPBAccruedInterestAndPenalty" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_GNPBAccruedInterestAndPenalty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CommonSharesToBeIssuedWith12SecuredPromissoryNotes" xlink:label="loc_GNPBCommonSharesToBeIssuedWith12SecuredPromissoryNotes" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_GNPBCommonSharesToBeIssuedWith12SecuredPromissoryNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/BalanceSheetsParenthetical" xlink:title="0003 - Statement - Condensed Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StatementsOfOperations" xlink:title="0004 - Statement - Condensed Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingCostsAndExpenses" xlink:label="loc_us-gaapOperatingCostsAndExpenses" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOperatingCostsAndExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CostOfLionTransaction" xlink:label="loc_GNPBCostOfLionTransaction" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_GNPBCostOfLionTransaction" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_SalesRevenueGoodsNet" xlink:label="loc_us-gaapSalesRevenueGoodsNet" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapSalesRevenueGoodsNet" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CostToInduceExchangeTransaction" xlink:label="loc_GNPBCostToInduceExchangeTransaction" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_GNPBCostToInduceExchangeTransaction" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:label="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StatementsOfOperationsParenthetical" xlink:title="0005 - Statement - Condensed Statements of Operations (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StatementsOfCashFlows" xlink:title="0006 - Statement - Condensed Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_FairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:label="loc_GNPBFairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" />
      <link:calculationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBFairValueOfCommonStockAndWarrantsAccountedForAsFinancingCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="loc_us-gaapAccretionAmortizationOfDiscountsAndPremiumsInvestments" />
      <link:calculationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_PrivatePlacementCosts1" xlink:label="loc_GNPBPrivatePlacementCosts1" />
      <link:calculationArc order="700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBPrivatePlacementCosts1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="800" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CommonStockIssuedToOfficerForServices" xlink:label="loc_GNPBCommonStockIssuedToOfficerForServices" />
      <link:calculationArc order="900" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBCommonStockIssuedToOfficerForServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="1000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CommonStockIssuedConversionOfWarrants" xlink:label="loc_GNPBCommonStockIssuedConversionOfWarrants" />
      <link:calculationArc order="1100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBCommonStockIssuedConversionOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CommonStockIssuedforRepricingShares" xlink:label="loc_GNPBCommonStockIssuedforRepricingShares" />
      <link:calculationArc order="1200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBCommonStockIssuedforRepricingShares" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_FairValueOfCommonStockTransferredToOfficerAndDirector" xlink:label="loc_GNPBFairValueOfCommonStockTransferredToOfficerAndDirector" />
      <link:calculationArc order="1300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBFairValueOfCommonStockTransferredToOfficerAndDirector" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_WriteOffOfAdvancesToRelatedParty" xlink:label="loc_GNPBWriteOffOfAdvancesToRelatedParty" />
      <link:calculationArc order="1400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBWriteOffOfAdvancesToRelatedParty" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="1500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="1600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_FairValueOfVestedWarrantsGrantedForServices" xlink:label="loc_GNPBFairValueOfVestedWarrantsGrantedForServices" />
      <link:calculationArc order="1700" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBFairValueOfVestedWarrantsGrantedForServices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CommonStockIssuedToInduceExchangeTransaction" xlink:label="loc_GNPBCommonStockIssuedToInduceExchangeTransaction" />
      <link:calculationArc order="1800" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBCommonStockIssuedToInduceExchangeTransaction" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants" xlink:label="loc_GNPBFairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants" />
      <link:calculationArc order="1900" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBFairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_CommonStockIssuedWithNotePayableReflectedAsFinancingCost" xlink:label="loc_GNPBCommonStockIssuedWithNotePayableReflectedAsFinancingCost" />
      <link:calculationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBCommonStockIssuedWithNotePayableReflectedAsFinancingCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_AccruedInterestAndPenalty1" xlink:label="loc_GNPBAccruedInterestAndPenalty1" />
      <link:calculationArc order="2300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_GNPBAccruedInterestAndPenalty1" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:label="loc_us-gaapPaymentsToFundLongtermLoansToRelatedParties" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders" xlink:label="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholders" />
      <link:calculationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToOfficersAndStockholders" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2013/elts/us-gaap-2013-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="gnpb-20130930.xsd#GNPB_ProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:label="loc_GNPBProceedsFromIssuanceOfSecuredPromissoryNotesNet" />
      <link:calculationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_GNPBProceedsFromIssuanceOfSecuredPromissoryNotesNet" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StatementsOfStockholdersEquityDeficiency" xlink:title="0007 - Statement - Statements of Stockholders' Equity (Deficiency)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/GeneralOrganizationAndBusiness" xlink:title="0008 - Disclosure - 1. GENERAL ORGANIZATION AND BUSINESS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPractices" xlink:title="0009 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/RestructuringOfDebt" xlink:title="0010 - Disclosure - 3. RESTRUCTURING OF DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/A.IntellectualPropertyLicenses" xlink:title="0011 - Disclosure - 3A. INTELLECTUAL PROPERTY LICENSES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/EquityRestructuring" xlink:title="0012 - Disclosure - 4. EQUITY RESTRUCTURING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/A.7SeniorSecuredConvertiblePromissoryNotes" xlink:title="0013 - Disclosure - 4A. 7% SENIOR SECURED CONVERTIBLE PROMISSORY NOTES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/B.12SecuredPromissoryNotes" xlink:title="0014 - Disclosure - 4B. 12% SECURED PROMISSORY NOTES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/C.September2012SecuredPromissoryNotes" xlink:title="0015 - Disclosure - 4C. SEPTEMBER 2012 SECURED PROMISSORY NOTES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/DerivativeLiabilities" xlink:title="0016 - Disclosure - 5. DERIVATIVE LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/A.CommonStock" xlink:title="0017 - Disclosure - 5A. COMMON STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StockOptionsAndWarrants" xlink:title="0018 - Disclosure - 6. STOCK OPTIONS AND WARRANTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/LicenseAndCommitments" xlink:title="0019 - Disclosure - 7. LICENSE AND COMMITMENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/RelatedPartyTransactions" xlink:title="0020 - Disclosure - 8. RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/SubsequentEvents" xlink:title="0021 - Disclosure - 9. SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesPolicies" xlink:title="0022 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesTables" xlink:title="0023 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/DerivativeLiabilitiesTables" xlink:title="0024 - Disclosure - 5. DERIVATIVE LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StockOptionsAndWarrantTables" xlink:title="0025 - Disclosure - 6. STOCK OPTIONS AND WARRANT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/SubsequentEventsTables" xlink:title="0026 - Disclosure - 9. SUBSEQUENT EVENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/GeneralOrganizationAndBusinessDetailsNarrative" xlink:title="0027 - Disclosure - 1. GENERAL ORGANIZATION AND BUSINESS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesDetails" xlink:title="0028 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/SummaryOfSignificantAccountingPracticesDetailsNarrative" xlink:title="0029 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING PRACTICES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/DerivativeLiabilitiesDetails" xlink:title="0030 - Disclosure - 5. DERIVATIVE LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StockOptionsAndWarrantsDetails" xlink:title="0031 - Disclosure - 6. STOCK OPTIONS AND WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/StockOptionsAndWarrantsDetails1" xlink:title="0032 - Disclosure - 6. STOCK OPTIONS AND WARRANTS (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/A.StockOptionsAndWarrantsOptionActivityDetails" xlink:title="0033 - Disclosure - 6A. STOCK OPTIONS AND WARRANTS Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://genesis-biopharma.com/role/A.StockOptionsAndWarrantsWarrantActivityDetails1" xlink:title="0034 - Disclosure - 6A. STOCK OPTIONS AND WARRANTS Warrant Activity (Details 1)" />
</link:linkbase>
